Evaluating the care cascade after antiretroviral therapy initiation in Latin America.
Evaluating the care cascade after antiretroviral therapy initiation in Latin America.
复制标题
DOI:
10.1177/0956462417714094
复制
发表时间:
2018-01
影响因子:
1.4
通讯作者:
Caribbean, Central and South America network for HIV epidemiology (CCASAnet)
中科院分区:
文献类型:
--
作者:
Wolff MJ;Cortes CP;Mejìa FA;Padgett D;Belaunzarán-Zamudio P;Grinsztejn B;Giganti MJ;McGowan CC;Rebeiro PF;Caribbean, Central and South America network for HIV epidemiology (CCASAnet)
Accelerating antiretroviral therapy (ART) administration, improving retention, and achieving viral suppression in low- and middle-income countries must be prioritized. We evaluated trends and disparities in these milestones in a large Latin American cohort. Adults starting ART (ARTstart) from 2003 to 2014 at Caribbean, Central, and South America network for HIV epidemiology sites were assessed for care cascade outcomes: CD4 cell count >200 cells/mm3 at ARTstart; retention (≥1 visit at one year after ARTstart); viral suppression (≥1 HIV-1 RNA <200 copies/ml at one year after ARTstart). Modified Poisson regression provided adjusted prevalence ratios by age, gender, and HIV transmission risk, accounting for site and year of ARTstart. Proportions achieving ARTstart and suppression improved over time (p < 0.05). Older age was associated with better retention and viral suppression, but not ARTstart at CD4 cell count >200 cells/mm3. Females and men who have sex with men (MSM) were more likely to have CD4 cell count >200 cells/mm3 at ARTstart. Injection drug users (IDUs) were less likely to be retained while MSM were more likely to achieve viral suppression (all p <0.05). Despite improvements in these outcomes over the course of a decade in this cohort, significant disparities existed, disadvantaging younger patients, men, and IDUs. These gaps indicate continued progress in providing early diagnosis and ARTstart remain critical.
登录
查看更多内容
影响因子:
3.6
作者:
Yiannoutsos CT;Johnson LF;Boulle A;Musick BS;Gsponer T;Balestre E;Law M;Shepherd BE;Egger M;International Epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration
通讯作者:
International Epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration
DOI:
10.1016/s0140-6736(10)60829-x
发表时间:
2010-07-31
期刊:
Lancet (London, England)
影响因子:
--
作者:
Altice FL;Kamarulzaman A;Soriano VV;Schechter M;Friedland GH
通讯作者:
Friedland GH
DOI:
10.1097/qai.0b013e3181d73e1b
发表时间:
2010-08-01
影响因子:
3.6
作者:
Tassie, Jean-Michel;Baijal, Parijat;Souteyrand, Yves
通讯作者:
Souteyrand, Yves
DOI:
10.1097/qai.0000000000000489
发表时间:
2015-04-01
期刊:
Journal of acquired immune deficiency syndromes (1999)
影响因子:
--
作者:
Yehia BR;Rebeiro P;Althoff KN;Agwu AL;Horberg MA;Samji H;Napravnik S;Mayer K;Tedaldi E;Silverberg MJ;Thorne JE;Burchell AN;Rourke SB;Rachlis A;Mayor A;Gill MJ;Zinski A;Ohl M;Anastos K;Abraham AG;Kitahata MM;Moore RD;Gebo KA;North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)
通讯作者:
North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)
影响因子:
6
作者:
Rebeiro, Peter F.;Cesar, Carina;Cahn, Pedro
通讯作者:
Cahn, Pedro